Solve.Care Partners with Leading Pharmaceutical Company Boehringer Ingelheim to Launch Care Network for Patients with Diabetes
Solve.Care has announced a collaboration with Boehringer Ingelheim Pharmaceuticals, Inc., to launch a patient-centric care network on the Solve.Care platform. The Diabetes Care Administration Network aims to improve the well-being of patients with diabetes, and who may also be at an increased risk for cardiovascular disease.
Initially, the network will be available to more than 25,000 patients through Arizona Care Network (ACN), a leading accountable care organization in the U.S. and a current client of Solve.Care. ACN will provide concierge care management and support care coordinators, with the goal of achieving better healthcare outcomes for participating patients. Based on the results of this initial launch, expansion opportunities in the U.S. and globally will be evaluated.
A very important and innovative element of the platform and the Diabetes Care Administration Network is the ability of family members to coordinate the care of their loved ones. It is not just the patient, but the community around and chosen by the patient, that is engaged and empowered to make important choices in how and when care is coordinated and provided.
The care network is expected to go live on or before year-end 2019.
Read the full official announcement.
Company Name: KuCoin
Contact Person: Media Relations
Email: Send Email